SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a significant insider share purchase by director Lawrence Cheng, which has boosted bullish sentiment alongside optimism surrounding the company's fiscal second-quarter profit and record operating income. While some traders view this as a potential precursor to further positive developments or a share buyback, others remain skeptical, citing continued revenue declines and a lack of direct communication from management.

ServiceTitan, Inc. engages in the collection of field service activities required to install, maintain, and service the infrastructure and systems of residences and commercial buildings. The company was founded by Ara Mahdessian and Vahe Kuzoyan on June 8, 2008 and is headquartered in Glendale, CA.

ServiceTitan Inc. - Ordinary Shares - Class A

ServiceTitan 

ServiceTitan shares dropped significantly following second-quarter earnings that beat revenue and earnings expectations but featured light revenue guidance for the third quarter and the resignation of its Chief Revenue Officer. Traders are debating whether the reaction is an excessive overreaction to minor guidance adjustments or a fundamental reset amid volatility in the software sector.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group shares are trending due to ongoing community debate regarding the stock's recent price volatility following its latest earnings report, with many traders viewing the movement as a period of institutional accumulation despite concerns over regulatory investigations. While some investors express frustration with the recent downward pressure, others maintain a bullish outlook based on the company's long-term growth prospects and share buyback program.

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Opus Genetics Inc.

Opus Genetics (IRD) is experiencing significant volatility driven by the release of positive topline results from its Phase 3 VEGA-3 trial evaluating Phentolamine Ophthalmic Solution for presbyopia. While the community is reacting to the clinical milestone and discussing potential price targets, many traders are expressing frustration over the stock's failure to maintain premarket gains and are debating the impact of recent and potential future equity offerings.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores is facing significant volatility following fiscal Q1 earnings that surpassed analyst expectations on both top and bottom lines. Traders are debating the pullback, with some viewing the drop as an overreaction to stagnant full-year guidance and capital spending, while others remain skeptical of the stock's valuation after a strong year-to-date rally.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as investors anticipate updates on its rolling New Drug Application (NDA) and upcoming earnings, with sentiment bolstered by positive clinical trial progress for its treatment-resistant depression therapy. The community remains focused on the company's first-mover advantage and potential for expedited regulatory approval, though some traders are debating the competitive landscape and commercialization risks.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is trending as the stock undergoes a significant price recovery following a sharp decline triggered by earnings results and guidance updates. Investors are debating whether the recent drop due to customer acquisition cost challenges represents an oversold buying opportunity or long-term fundamental risk.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending following the launch of Muse, a personal AI agent designed to perform real-world tasks, which sparked debate among traders regarding the effectiveness of AI spending and the company's ability to drive durable monetization. Sentiment remains polarized as investors weigh the potential for increased engagement against concerns over high capital expenditures.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing selling pressure as traders speculate on insider selling and express frustration with recent price volatility. While some participants highlight the company's strong fundamentals and future roadmap, many are waiting for further technical consolidation or a deeper pullback before adding to positions.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as it sustains strong bullish momentum, with traders debating whether the asset represents a superior, quantum-proof alternative to Bitcoin while closely monitoring a high-profile, multi-million dollar short position that is facing potential liquidation. Sentiment remains largely optimistic among the community, as many point to the coin's privacy features and limited supply as catalysts for a potential short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday

U.S. stocks fell, but Caleres surged 14% on strong results and higher guidance. Opus Genetics, Signet and Oddity also posted big gains.read more...

Five High-Voltage Stories in Focus

The market is once again rewarding investors who know where to look for catalysts, bioAffinity Technologies (NASDAQ:BIAF), NeOnc Technologies Holdings (NASDAQ:NTHI), Opus Genetics (NASDAQ:IRD), Eos Energy Enterprises (NASDAQ:EOSE) with Google (NASDAQ:GOOG), and Scorpio Gold (NASDAQ:SGLD) each have a distinctly different catalyst driving their narratives.

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates

Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of +6.67% and -75.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates

Qiagen (QGEN) delivered earnings and revenue surprises of +3.33% and +1.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup

RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup...

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates

Opus Genetics, Inc. (IRD) delivered earnings and revenue surprises of -374.68% and -23.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Certara, Inc. (CERT) Q1 Earnings Miss Estimates

Certara (CERT) delivered earnings and revenue surprises of -20.57% and +1.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Opus Genetics, Inc. (NASDAQ:IRD) Receives Average Recommendation of "Moderate Buy" from Analysts

Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the thirteen analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating...

Opus Genetics (NASDAQ:IRD) Now Covered by Analysts at Citizens Jmp

Citizens Jmp initiated coverage on Opus Genetics in a report on Tuesday. They issued a "market perform" rating and a $12.00 price target for the company...

Insider Selling: Opus Genetics (NASDAQ:IRD) President Sells 7,470 Shares of Stock

Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) President Benjamin Yerxa sold 7,470 shares of the firm's stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $5.24, for a total transaction of $39,142.80. Following the sale, the president owned 711,535...

Extremely Bullish Sentiment

Yes, hike is locked in

No, inflation data still matters more

Fed stays on hold anyway

Too early to tell

August nonfarm payrolls surged by 162,000, nearly triple the 53,000-56,000 consensus estimate and the strongest monthly gain since March, while unemployment held steady at 4.1%, adding fuel to the case for a Federal Reserve rate hike at its September meeting. Does this jobs report cement a September rate hike? Vote and explain your reasoning in the comments.

August nonfarm payrolls surged 162,000, nearly triple estimates, while unemployment held at 4.1%. Does this cement a September rate hike?

Stocktwits

Stocktwits Polls

Positive Phase 1/2 clinical trial data and FDA alignment on Phase 3 trials have triggered significant bullish sentiment.

Traders are actively monitoring heavily shorted levels for a potential breakout toward $8 and beyond.

Investors are setting ambitious technical price targets with many eyeing double digits following recent momentum.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IRD Opus Genetics Inc.

Fundamentals

Latest IRD News